Cannabis Credit Risk:
The Missing Piece in Cannabis Banking
Despite the challenges that financial institutions must overcome to expand into credit services for the cannabis industry, the future of cannabis banking will include lending and credit line programs.
10 min read
10 min read
The legal cannabis industry is often described as one of the most dynamic markets in the United States, with projected revenues to reach $80 billion by 20235. It is made up of 40 distinct markets that allow either medical or adult-use cannabis, yet despite its size, cannabis remains federally illegal, limiting interstate commerce and presenting challenges in banking and financing.
For banks, credit unions, and private lenders, the decision to serve cannabis-related businesses (CRBs) is rarely straightforward. Regulatory guidance is incomplete, compliance requires substantial resources and time, and traditional credit risk models often fall short. Still, the economic opportunity is undeniable. A sector of this scale will not remain outside mainstream finance forever, and the financial institutions that can bridge the gap between compliance and opportunity may secure one of the most lucrative lending markets in decades.
From Deposits to Lending: A Market in Transition
The first phase of cannabis banking was defined by access. When states began legalizing medical and recreational sales, most cannabis businesses were locked out of traditional banking options. Unable to open checking accounts or process payments electronically, CRBs relied heavily on cash. This not only created operational inefficiencies but also heightened risks of theft, tax evasion, and money laundering.
In response, a small but growing number of banks and credit unions began offering basic depository services. These institutions relied on the 2014 Financial Crimes Enforcement Network (FinCEN) guidance, which outlined how financial institutions could serve cannabis businesses while complying with the Bank Secrecy Act (BSA) and Anti-Money Laundering (AML) rules. By following enhanced due diligence steps and filing cannabis-specific Suspicious Activity Reports (SARs), banks could provide services without running afoul of regulators.
Depository services solve an immediate banking access problem, but they do not address the long-term capital needs of this maturing sector. Today, hundreds of FIs take cannabis deposits, but financial services like lending and lines of credit, which are a major revenue generator for financial institutions, remain limited. Without reliable tools for measuring cannabis credit risk, FIs providing lending proceed with uncertainty and limited visibility into the operational and financial health of CRBs.
The future of cannabis banking will include lending and credit line programs. As CRBs look to expand operations, invest in infrastructure, and compete in increasingly saturated markets, the demand for credit financing will continue to grow.
The Compliance Burden
FIs that decide to launch a cannabis banking program must begin with a review of existing cannabis market conditions and regulations and understand cannabis finance regulations.
At the onboarding stage, every license must be verified for authenticity and validity as state cannabis programs often require CRBs to hold numerous state agency permits and local jurisdictional licenses. FIs should work with 3rd party providers to help them verify account ownership information that is often times made up of complex ownership structures. Many CRBs have layered entities, investor pools, or joint ventures that make beneficial ownership difficult to trace. Depending on how state cannabis programs are structured, some owners are permitted to hold multiple licenses across several jurisdictions, requiring enhanced due diligence and research.
Once an account is opened, the compliance work intensifies. Transaction monitoring is both constant and nuanced. Large cash deposits are expected in cannabis and FIs must be able to distinguish between legitimate sales revenue and suspicious activity. License status changes are not uncommon, meaning institutions must engage in perpetual Know Your Customer (KYC) reviews. In practice, this often extends to “Know Your Customer’s Customer” (KYCC), as the interconnected nature of the supply chain makes it impossible to evaluate one business in isolation.
Banking regulators have made clear that adherence to the FinCEN guidance is only a starting point. Examiners expect robust program governance, comprehensive policies, and transparent documentation of how clients are evaluated. For banks, the stakes are high as falling short risks both regulatory penalties and reputational harm.
Why Cannabis Credit Risk Requires a New Playbook
For FIs, the opportunity to offer extended financial services to CRB accounts and generate new revenue will require them to create smart lending programs that are both profitable and compliant. While compliance dominates the conversation, the real obstacle to cannabis lending lies in industry specific credit risk evaluation. Traditional underwriting frameworks, in addition to traditional business risk assessments, rely on predictable inputs: consistent financial history, understood collateral values, and stable regulatory environments. Cannabis offers few of these.
Most cannabis companies are still relatively young, with only a handful of years in operation. Even those with track records often show volatile earnings shaped by state tax structures, cash-heavy operations, and fluctuating wholesale prices. This makes it difficult to assess long-term viability using conventional methods.
Collateral complicates matters further. A cannabis license may be a prized asset in a limited-license state, but in an open-license market it holds far less value, and state cannabis program regulations often restrict licenses being transferred to creditors in case of default. Real estate tied to cannabis operations is often leased instead of owned. Inventory, while tangible, is generally not an option due to restrictions in regulations and the lack of consistency in product value over time. Specialized equipment used in processing and cultivation facilities has little value outside the industry. Bank factoring, also known as accounts receivable (AR) funding, may be used to collateralize loans and lines of credit by using outstanding invoices as security, but it requires extensive KYCC and 3rd party audits of the AR.
The regulatory environment adds another variable. State frameworks evolve frequently, sometimes with dramatic implications. A change in state and local tax and fee structure, operational regulations, or new product testing standards can impact a business’s risk profile. For lenders, this volatility underscores the need for industry-specific risk models that account for regulatory, operational, and financial dynamics unique to cannabis.
Building Confidence with Data
The path forward in cannabis lending hinges on data. Reliable, standardized information about CRBs is the foundation of any sustainable credit program. This includes more than financial statements, and must consider licensing records, compliance histories, ownership details, seed to sale data, and other license type specific like point of sale and testing results.
Industry-specific credit risk models can translate all of this information into actionable insights. With comparable benchmarks across jurisdictions and business types, FIs can distinguish healthy CRBs from distressed ones and price loans accordingly. These models also provide a defensible framework for regulators, demonstrating that lending programs are consistent, transparent, and aligned with safety-and-soundness principles.
Some FIs are already experimenting with this approach. A handful of banks and credit unions have begun lending to CRBs on a limited basis, but most are doing so without a comprehensive credit risk analysis and ongoing monitoring solutions. Scaling these lending programs will require the adoption of standardized risk models, utilizing tools that place credit risk analysis front and center in their underwriting and monitoring processes.
Toward a Mature Cannabis Finance Ecosystem
As the cannabis industry evolves, access to credit will play a defining role in shaping its trajectory. Depository services solved the immediate problem of cash management, but they did not address the growth needs of a capital-intensive sector. Cultivators need loans to expand facilities, manufacturers require financing for equipment, and retailers must invest in storefronts and inventory. Without access to credit through FIs, these businesses must either turn to high-cost credit alternatives from private lenders or continue to operate without growth capital.
For FIs, cannabis lending is not just about capturing a new revenue stream. It is about shaping the future of a regulated industry. By extending capital responsibly, FIs can help professionalize cannabis finance, reduce reliance on predatory lenders, and demonstrate to regulators that the market can be capitalized within the safety of the institutional finance system.
The Regulatory Horizon
Federal policy adds another layer of uncertainty for most FIs still waiting on the sidelines. Legislation such as the SAFER Banking Act, which would explicitly protect banks serving CRBs has been introduced multiple times in Congress but has yet to pass. Each new attempt sparks optimism, but the lack of progress leaves FIs navigating the same legal gray zone that has defined the industry for a decade.
Even without new federal laws, regulators continue to press FIs to treat cannabis as they would any other high-risk sector: with rigor, consistency, and transparency. That expectation means credit programs must be built not just for profitability but also for defensibility. Every decision must be explainable to examiners, every risk model supported by data, and every loan documented with governance frameworks that can withstand scrutiny.
And while cannabis banking has always been defined by its challenges, FIs that build robust cannabis credit risk frameworks can move beyond compliance as a defensive posture and turn it into a competitive edge. By doing so, they position themselves not only to meet regulatory expectations but also to lead in a significant new lending market with tremendous growth potential.
FAQs
The Cost of Inaction
For CRBs, lack of access to affordable credit has created a reliance on expensive private equity and in many cases, egregious lending arrangements. This not only raises the cost of capital but also entrenches inequities, as well-connected or well-capitalized players gain advantages over smaller businesses through existing financial networks.
For cannabis program regulators, there is growing concern about the risks of private equity lending schemes, where predatory practices thrive and oversight is minimal. The shift from equity ownership investment, which provides a clear view into the funding mechanisms for CRBs, to private debt gives regulators far less transparency into the financing of CRBs.
The cannabis industry’s growth demands capital far beyond what private investors can provide. For FIs, this gap represents a multi-billion-dollar opportunity to bring transparency, stability, and scale to a market that has remained only partially engaged with the larger financial system. FIs that hesitate may miss a first-mover advantage. Lending markets, once established, tend to consolidate around early entrants. FIs that develop smart cannabis lending programs today will be positioned to capture disproportionate market share tomorrow.
The cannabis sector will continue to carry unique risks. But in banking, risk has always been the raw material of opportunity. For those willing to invest in smart programs that build off strong governance, defensible policies, and specialized credit risk models utilizing industry specific data, cannabis lending may prove less a regulatory headache and more a defining growth story of the next decade.
Ready to Get Expert Guidance?
Our team partners with banks, credit unions, and lenders to turn complex cannabis credit risk into lending opportunities.
Let’s find the right path forward together.